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doi:10.1016/j.jtcvs.2008.04.002Objectives: Low cardiac output state is the principal cause of morbidity after surgical in-
tervention for congenital heart disease. Myocardial ischemia–reperfusion injury, apopto-
sis, capillary leak syndrome, and myocardial edema are associated factors. We established
a clinically relevantmodel to examine relationships between myocardial ischemia, edema,
and cardiac dysfunction and to assess the role of the water transport proteins aquaporins.
Methods: Sixteen lambs were studied. Seven were control animals not undergoing
cardiopulmonary bypass, and 9 underwent bypass. Six had 90 minutes of aortic cross-
clamping with blood cardioplegia and moderate hypothermia. The remaining 3 under-
went cardiopulmonary bypass without aortic crossclamping. Hemodynamic and
biochemical data were recorded, and myocardial edema, apoptotic markers, and aqua-
porin expression were determined after death.
Results: The group undergoing cardiopulmonary bypass with aortic crossclamping
had a low cardiac output state, with early postoperative tachycardia, hypotension, in-
creased serum lactate levels, and impaired tissue oxygen delivery (P, .05) compared
with the group undergoing cardiopulmonary bypass without aortic crossclamping.
The lambs undergoing cardiopulmonary bypass with aortic crossclamping had in-
creased myocardial water (P , .05) compared with those not undergoing cardiopul-
monary bypass and a 2-fold increase in aquaporin 1 mRNA expression (P , .05)
compared with those not undergoing cardiopulmonary bypass and those undergoing
cardiopulmonary bypass without aortic crossclamping.
Conclusions: A temporal association between hemodynamic dysfunction, myocardial
edema, and increased aquaporin 1 expression was demonstrated. Cardiopulmonary
bypass without ischemia was associated with minimal edema, negligible myocardial
dysfunction, and static aquaporin expression. Ischemic reperfusion injury is the main
cause of myocardial edema and myocardial dysfunction, but a causal relationship
between edema and dysfunction remains to be proved.
L
ow cardiac output state (LCOS) is the most important cause of morbidity and
mortality after infant cardiac surgery.1 LCOS is caused by contractile failure
coupled with compensatory increases in circulatory afterload.2 Clinically,
LCOS is apparent as reduced perfusion pressure, increased heart rate, reduced oxygen
delivery, and increased inotropy.1 With time, LCOS resolves, but its legacy is appar-
ent as renal and sometimes neurologic impairment. Overall outcomes after infant car-
diac surgery are excellent, but patients with high-risk lesions, such as hypoplastic left
heart syndrome, and those undergoing major reconstructions still experience mortality
and important morbidity as a result of LCOS.3 Improvements in supportive practicesThe Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1265
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CSPAbbreviations and Acronyms
AQP 5 aquaporin
AXC 5 aortic crossclamping
COP 5 colloid osmotic pressure
CPB 5 cardiopulmonary bypass
I/R 5 ischemia and reperfusion
LCOS 5 low cardiac output state
TUNEL 5 TdT-mediated dUTP nick-end labeling
have reduced LCOS,1 but minimal progress has been made in
understanding the underlying causes, and standard pediatric
myocardial protection strategies have remained static for
15 years.
LCOS occurs early, during the first 6 to 12 hours postop-
eratively, and is temporally associated with increased total
body water content and generalized tissue edema.4,5 Capillary
leak syndrome and myocardial edema have a similar time
course after pediatric cardiac surgery and appear integral to
LCOS, with many clinicians asserting a causal relationship.4,6
Studies of cardiac ultrastructure have demonstrated myocellu-
lar and mitochondrial edema after ischemia and reperfusion (I/
R).7 Increased myocardial water content has been associated
with myocardial dysfunction, both systolic8 and diastolic.9
Small increases in myocardial water (increase of 3%) have
been shown by Laine and Allen,10 in an animal model, to sig-
nificantly affect myocardial function (decrease of 30%).
Myocardial edema can develop through a combination of
vasogenic and cytotoxic pathways. Typically, interstitial or
vasogenic edema is described11,12 and associated with in-
creased capillary leak. Intracellular or cytotoxic edema also oc-
curs13,14 as a result of the osmotic effect of lactate accumulated
by the myocyte during anaerobic metabolism. Existing anti–
inflammatory therapies, such as corticosteroids and aprotinin,
that seek to target the systemic inflammatory response syn-
drome do not prevent the extravasation of water,6,12,15 leading
us to investigate other possible avenues of intervention, such as
the role of water channels or aquaporins (AQPs).15
AQPs are a family of 13 proteins that form transmembrane
channels permitting rapid movement of water along osmotic
gradients. We and others have demonstrated that AQP1 is the
main myocardial AQP that exists within the endothelium and
cardiomyocyte plasma membranes.14,16,17 In human hearts
other AQPs have been demonstrated only at a transcript
level.14 AQPs in the brain have been shown to be important
in animal models after ischemic stroke and water intoxica-
tion; for example, AQP4 knockout mice have significantly
less cerebral edema and improved function compared with
that seen in wild-type mice after these insults.18 Given
some of the pathophysiologic similarities, it is conceivable
that AQPs within the heart could also be involved in the de-
velopment or resolution of myocardial edema and LCOS.1266 The Journal of Thoracic and Cardiovascular Surgery c NoA role for AQPs in myocardial water handling has been
shown in osmotically challenged isolated cardiomyocytes,19
and myocardial AQPs have been increasingly studied in
relevant models,17,20,21 including our work with isolated car-
diomyocytes and isolated heart preparations in response to
I/R and hypo–osmotic stress.17 These studies demonstrated
a physiologic role but no apparent change in AQP expression
during the short time frame possible with these in vitro exper-
iments.17 Furthermore, the role of cardiopulmonary bypass
(CPB) in water handling is difficult to reproduce in vitro.
Consequently, we have produced a clinically accurate model
of infant LOCS to assess changes in myocardial AQP expres-
sion in this setting.
Induction of apoptotic pathways has been suggested as
a mechanism of cell loss contributing to LCOS and later ven-
tricular dysfunction in the pediatric setting.22 Using the same
model, we sought to evaluate the extent to which apoptosis
was evident in control hearts, as well those undergoing
CPB with or without aortic crossclamping (AXC).
Materials and Methods
The Animal Ethics Committee at The Children’s Hospital at West-
mead approved this study, and all animals received humane care in
compliance with National Health and Medical Research Council
animal care guidelines.
Study Design
Sixteen lambs of either sex weighing 7.4 6 0.4 kg were used.
Non-CPB control animals. There were 7 control animals that
underwent cardiectomy without receiving CPB (non-CPB control
animals). Lambs were prepared and monitored as for the CPB
groups and maintained under anesthesia for 1 hour before cardiec-
tomy. Cardiac standstill was achieved after a terminal dose of cardi-
oplegia in 4 of the 7 control animals. Blood was obtained from the
ewe for the purpose of making blood cardioplegia. The other 3 non-
CPB control animals were killed with pentobarbitone, also during
anesthesia with the sternum open, allowing rapid cardiectomy and
specimen preservation. These 2 approaches were used to account
for the effect of cardioplegia on myocardial water content because
it is recognized that cardioplegia administration itself increases
myocardial water content.9
CPB groups. Of the 9 lambs undergoing CPB, 3 underwent 90
minutes of bypass without AXC (CPB-AXC) and were maintained
for 3 hours after separation from bypass. The remaining 6 had AXC
and were maintained for either 3 (n5 3) or 6 (n5 3) hours after sep-
aration from bypass. Lambs were chosen because of physiologic
similarities to infant humans and because DNA sequences for
AQPs are published for the sheep, unlike the pig.
Experimental preparation. Neonatal lambs were anesthetized
by means of spontaneously breathing isoflurane and given intrave-
nous ketamine (1 mg/kg) and midazolam (100 mg/kg). The lamb
was intubated with a 5.5 mm cuffed endotracheal tube. Ventilation
was maintained with a Campbell ventilator (ULCO, Marrickville,
New South Wales, Australia), aiming for physiologically normal
oxygen saturations (100%) and PaCO2 values (40–45 mm Hg);
typical ventilation parameters were 20 to 25 cm H2O on 5 cmvember 2008
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PH2O in 100% oxygen. General anesthesia was maintained with in-
haled isoflurane (0.1%–1%) continuously through the circuit, and
intermittent ketamine, midazolam, and pancuronium were also ad-
ministered as required. Intravenous flucloxacillin (25 mg/kg) was
given every 6 hours. A 3–lumen, 4.5F, 13-cm central line (Arrow,
Reading, Pa) was placed percutaneously into the right internal jug-
ular vein. A single lumen (20-cm, 3F catheter; Cook, Bloomington,
Ind) was inserted percutaneously into the right femoral artery. Cuta-
neous 3-lead electrocardiography, rectal temperature, central venous
pressure, and intra–arterial pressure were monitored continuously.
Venous and arterial blood gases were taken regularly.
CPB technique. Midline sternotomy was performed, and the
pericardium was opened. CPB was established after heparin admin-
istration (400 IU/kg) with right atrial and ascending aortic cannula-
tion. The extracorporeal circuit was established with a heart–lung
machine (Cobe, Arvada, Colo). A standard 1/4 -
1/4 – or
1/4 -3/8–
inch bypass circuit was used connected to a Terumo RX5 or
SX10 oxygenator with an open venous reservoir and Terumo Cap-
iox AF02 arterial filter (Terumo, Tokyo, Japan). About 90% of the
bypass circuit prime volume was composed of maternal sheep blood
and about 10% of Baxter Plasma Lyte-148-Replacement fluid
(Baxter, Old Toongabbie, New South Wales, Australia) buffered
with sodium bicarbonate and about 3 units of heparin per milliliter
of prime fluid. Nonpulsatile flow rates were adjusted to maintain
a flow rate of approximately 150 mL $ kg21 $ min21 and mean sys-
temic pressures between 30 to 40 mm Hg. If necessary, the isoflur-
ane dose was also varied to maintain the desired blood pressure
range. The lambs’ core temperatures were slowly decreased to
28C to 30C with a heater-cooler unit (Conair-Churchill, Pitts-
burgh, Pa).
In the CPB1AXC group, after establishment of CPB, the aorta
was crossclamped and blood cardioplegia at 4C was administered
at 20 mL/kg into the proximal ascending aorta. The cardioplegia
comprised a 4:1 blood/crystalloid mix. This was delivered every
20 minutes into the aortic root for 90 minutes, at which point bypass
was weaned and the native circulation was re–established. The av-
erage composition of the initial CPB machine prime, which did
not significantly differ between treatment groups, was as follows:
pH, 7.6; PCO2, 24 mm Hg; PO2, 202 mm Hg; hematocrit, 21%; K,
4.4 mmol/L; Ca, 0.4 mmol/L; and bicarbonate, 21 mmol/L. Modi-
fied ultrafiltration was performed on all lambs undergoing CPB,
and internal defibrillation (0.5–1.0 J/kg), lignocaine (1 mg/kg), or
both were administered as required. Routine surgical techniques
in maintenance and weaning from CPB were used, including vent-
ing of the left atrial appendage in all cases.
Postoperative management. After the re-establishment of the
native circulation, protamine (1–3 mg/kg) was administered, and he-
mostasis was achieved. The sternotomy was closed over two 28F in-
trathoracic drains, which were placed on low-pressure wall suction.
Dopamine (approximately 5 mg $ kg21 $ min21) and sodium nitro-
prusside (approximately 1 mg $ kg21 $ min21) were commenced af-
ter CPB and adjusted as required to maintain an adequate blood
pressure (mean blood pressure, .50 mm Hg), crystalloid or mater-
nal blood was administered to maintain an adequate preload (central
venous pressure, .4 mm Hg), and hemoglobin (.8 g/dL) and
inhalational anesthesia were continued together with intermittent
intravenous agents (ketamine and midazolam) and pancuronium.
Ventilation was maintained and adjusted according to blood gas pa-
rameters. All animals were managed by a pediatric intensive careThe Journal of Thoraconsultant (JRE) using conventional techniques relevant to the
care of human infants.
Tissue collection. After either 3 (n 5 6) or 6 (n 5 3) hours of
reperfusion after bypass, the sternotomy was reopened, the aorta
was crossclamped, and a further dose of approximately 4C cardio-
plegia was delivered. After electrical and cardiac standstill for
approximately 60 seconds, the heart was removed and placed on
ice while dissected for further analysis. The heart was transversely
sectioned into the atria, great vessels, and ventricles. The ventricles
were sectioned for wet/dry weights and, together with other organ
tissues, were either frozen at 280C or placed in 4% paraformal-
dehyde for sectioning.
Tissue Analysis
Myocardial water content. Samples of intraventricular septum
and left and right free walls were weighed after blotting. They
were then dried at approximately 80C for 48 hours or until their
weights were static. Myocardial water content was then calculated
as {½WeightðwetÞ2WeightðdryÞ =WeightðwetÞ} and expressed as
a proportion.
Myocardial AQPs. Myocardial AQP1 mRNA and protein levels
were quantified in ventricular myocardium by using techniques we
have previously reported17 and elaborated on in Appendix E1.
Apoptosis. Assessment of apoptotic cell death was performed by
using the TdT-mediated dUTP nick-end labeling (TUNEL) assay
with the In Situ Cell Death Detection Kit (Roche, Basal, Switzer-
land). Positively labeled cells versus total cells were counted to
quantify cell death. The entire slide was scanned at high-power
magnification by an observer blinded to animal allocation (TLB).
Hematoxylin and eosin–stained slides were also reviewed in
a blinded fashion to review tissue integrity and exclude necrosis.
Western blots for active caspase 3 were prepared by using cytoplas-
mic fractions.
Statistical Analysis
Data are expressed as means 6 standard error of the mean. Statisti-
cal significance was determined by using both the Mann–WhitneyU
test and linear mixed models with covariance type AR–1. The statis-
tical package SPSSv15.0 for Windows (SPSS, Inc, Chicago, Ill) was
used for analysis. The animals receiving CPB6AXC were com-
pared in terms of hemodynamic variables, both functional and bio-
chemical. Hemodynamic variables were analyzed over the complete
survival period and also by means of comparison of 30-minute
epochs. Our sample size gave us 80% power to demonstrate that
a 2.3-standard-deviation effect size difference between groups was
significant at a P value of less than .05. For measures of myocardial
water content, AQP1 expression, and apoptosis, comparison was
made between non-CPB control animals and animals receiving
CPB6AXC.
Results
All experiments were completed as intended, and there were
no significant differences in pre-CPB hemodynamic values.
There were no inotropes or vasodilators administered before
CPB, and baseline biochemical indices, which were not sig-
nificantly different, are shown in Table E1. The animals re-
ceived similar weight-based doses of sedatives, analgesics,
anesthetics, and muscle relaxants.cic and Cardiovascular Surgery c Volume 136, Number 5 1267
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The hemodynamic picture of LCOS was seen in those animals
that underwent CPB1AXC (Figure 1). The lambs undergoing
CPB1AXC were more hypotensive after CPB. Mean blood
pressure was significantly less, as determined by mixed model
analysis (P , .01 after CPB). Diastolic blood pressure was
also significantly less, as determined by using mixed-model
analysis (P , .05 after CPB). The differences remained at
the end of the survival period. Systolic blood pressure was
lower in the CPB1AXC group, and this was significant by
means of the Mann–Whitney U test for the early and mid
epochs after CPB. Heart rate was higher in the CPB1AXC
group, also by means of the Mann–Whitney U test, in all
but the last post-CPB epoch. Central venous pressure, fluid
requirements, and doses of vasoactive medications did not
differ significantly between the groups.
Biochemistry
The CPB1AXC group had a higher lactate value (6.5 vs 3.6
mmol/L, P, .05) after CPB. However, by 3 hours after CPB,
the differences were not significant (3.1 mmol/L in the
CPB1AXC group and 2.1 mmol/L in the CPB–AXC group).
The CPB1AXC group had a persistently lower venous satu-
ration after CPB. The initial post-CPB venous saturation was
61% in the CPB1AXC group compared with 76.7% (P ,
.05) in the CPB–AXC group. The venous saturations at 3
hours after CPB were 70% and 83.8% (P, .05), respectively
(Figure 1). The glucose and hemoglobin levels remained sim-
ilar in the 2 CPB groups. The colloid osmotic pressure (COP)
was not significantly different between the 2 CPB groups at
any time after CPB. COP showed the expected increase after
modified ultrafiltration. In the CPB–AXC group it increased
from 12.3 mOsm to 14.5 mOsm, and in the CPB1AXC
group it increased from 13.5 mOsm to 15.7 mOsm. After
a further 3 hours, the COPs were 13 mOsm and 13.6
mOsm, respectively.
Myocardial Water Content
Myocardial water content was increased (not significantly) in
the tissue from control lambs that were killed after terminal
cardioplegia (0.785) as opposed to that seen in the control
lambs that received pentobarbitone (0.781). Myocardial wa-
ter content in the CPB–AXC group was 0.787, whereas in the
CPB1AXC group it was 0.796, which was significantly
greater than that seen in cardioplegia control tissue (P ,
.05). In summary, there was a 1% increase in myocardial wa-
ter content associated with CPB1AXC, with only a 0.2% in-
crease in myocardial water content in the CPB–AXC group
(Figure 2).
Molecular Results
Myocardial AQP1 mRNA levels, as determined by means of
quantitative real-time polymerase chain reaction, were in-
creased 2-fold in the CPB1AXC group compared with those1268 The Journal of Thoracic and Cardiovascular Surgery c Noseen in control tissue (P , .05). AQP1 mRNA levels in the
CPB1AXC group were also significantly higher when com-
pared with those in the CPB–AXC group (P, .05, Figure 3).
There was no associated increase in AQP1 levels on Western
blot analysis in either of the CPB groups (Figure 4). AQP4
transcript was not altered compared with that seen in control
animals in either CPB group, and low protein levels were also
unchanged by experimental group (data not shown). AQP0,
AQP3, and AQP9 transcript was detectable at low levels.
No appreciable changes were seen in these levels with quan-
titative real-time polymerase chain reaction (data not shown).
Protein for these 3 AQPs was not demonstrable by means of
Western blotting, despite appropriate antibodies and control
tissue (data not shown).
Apoptosis
Completed apoptosis was not demonstrable by means of TU-
NEL staining in any of the preparations to a significant degree.
Hematoxylin and eosin–stained slides also did not demon-
strate necrosis, although tissue edema was more apparent in
the CPB1AXC group. Levels of caspase 3 protein, an early
marker of apoptotic pathway induction,23 were significantly
increased in the CPB1AXC group. The control and CPB–
AXC groups had comparable levels of caspase 3 (Figure 5).
Discussion
Clinical and laboratory features of LCOS were reproduced in
a clinically accurate model in lambs that underwent CPB with
myocardial I/R. These animals also had significant gains in
myocardial water content and an increase in AQP1 transcript
levels that has not been previously described. These data
provide novel insights into the pathophysiology of capillary
leak syndrome and myocardial edema in the setting of post-
operative LCOS.
Hemodynamic changes consistent with LCOS were seen
immediately after CPB. In the CPB1AXC animals there was
significant tachycardia and systolic dysfunction. Impaired tis-
sue oxygen delivery and lower diastolic pressure also occurred
in those animals after CPB1AXC. CPB alone did not result in
significant hemodynamic or biochemical derangements; it was
I/R that was primarily associated with hemodynamic dysfunc-
tion and impaired tissue oxygen delivery. The primacy of I/R in
precipitating LCOS has been alluded to previously; however,
in some well-controlled animal experiments, this has not
been demonstrated.24,25 In our series CPB alone was well tol-
erated, and it was only when coupled with I/R that significant
perturbations in circulatory function resulted. Consequently,
measures to minimize the duration and effect of I/R should
be the focus of ongoing research into LCOS.
The greatest degree of myocardial edema was seen in those
animals after CPB with I/R. CPB without I/R was not associ-
ated with development of significant myocardial edema.
These data prompt a re-evaluation of the dogma surrounding
capillary leak and its contribution to the development ofvember 2008
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Pmyocardial edema after CPB. Ischemia is a potential con-
founder in several of the sentinel articles involved in asserting
the link between edema and dysfunction,11,26 and there have
been no previous attempts to experimentally differentiate the
contribution of ischemia to edema-associated dysfunction.
Edema does occur with CPB alone, and in our study it was
Figure 1. Hemodynamic and biochemical variables. In A through F, lambs are grouped as undergoing cardiopulmo-
nary bypass (CPB)without aortic crossclamping (AXC; solid line) and CPB with AXC (dashed line). A shows similar
heart rates between groups, but after CPB, the CPB1AXC group have a significantly higher heart rate until the last
30-minute epoch of postoperative analysis (Mann–Whitney U test). B displays systolic blood pressure, which is sig-
nificantly lower in the CPB1AXC group in the mid epochs after CPB (Mann–Whitney U test). C and D show mean
blood pressure and diastolic blood pressure, respectively, being significantly lower in the CPB1AXC group through-
out the postoperative period (mixed-model analysis). E demonstrates a higher lactate level in the CPB1AXC group
just before the completion of CPB (Mann–Whitney U test). In F there is a corresponding decrease in venous satu-
ration in this group, which remains throughout the postoperative period (Mann–Whitney U test). HR, Heart rate;
MBP, mean blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure. *P < .05. Data shown
are presented as means 6 standard error of the mean.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1269
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with significant myocardial dysfunction. It is likely that
edema in this group was mainly interstitial or vasogenic in na-
ture, resolved quickly, and was not associated with important
dysfunction. Others have shown that such edema might have
resolved within 6 hours.11 Hence it might have been possible
Figure 2. Myocardial water. Proportion of heart as water in non–
cardiopulmonary bypass (CPB) control animals (black column),
lambs undergoing CPB without aortic crossclamping (AXC; gray
column), and lambs undergoing CPB with AXC (white column).
Significant myocardial edema was present in lambs undergoing
CPB1AXC lambs, and a nonsignificant increase in myocardial
water occurred in those undergoing CPB–AXC (Mann–Whitney
U test). *P< .05. Data shown are presented as means 6 standard
error of the mean.
Figure 3. Myocardial aquaporin (AQP) 1 transcript expression.
RNAwas extracted from the myocardium of non–cardiopulmonary
bypass (CPB) control animals (black column), lambs undergoing
CPB without aortic crossclamping (AXC; gray column), and lambs
undergoing CPB1AXC (white column). The quantitative real-time
polymerase chain reaction results shown are representative of at
least 3 individuals in each group and are representative of 3 inde-
pendent sets of experiments. AQP1 mRNAwas normalized to ribo-
somal 18S RNA (Mann–Whitney U test). *P < .05 versus non-CPB
control animals and #P < .05 versus the CPB–AXC group. Data
shown are presented as means 6 standard error of the mean.1270 The Journal of Thoracic and Cardiovascular Surgery c Nto demonstrate more myocardial edema after CPB alone if we
had looked earlier in the postoperative period, but such a time-
frame would not correlate with LCOS and dysfunction seen 6
to 12 hours postoperatively.
In our study ischemia was associated with a greater degree
of edema formation and was associated with important
dysfunction, as has been described by others.27 The 1% in-
crease in myocardial water content that we observed after
I/R could be expected to result in possibly a 10% reduction
in myocardial function based on the work of Laine and Al-
len.10 We did not measure cardiac output or load-indepen-
dent measures of myocardial function, but the average
difference in mean blood pressure after CPB was 17 mm
Hg (22%) when comparing those with or without I/R in
our study. This suggests that other factors, and not edema
alone, are responsible. It is likely that I/R results in a greater
degree of interstitial or vasogenic edema that persists, as well
as cytotoxic or intracellular edema caused by accumulation
of lactate. Cytotoxic edema has been shown to be short last-
ing28 but might reflect important effects on the contractile
apparatus that persist for the duration of the LCOS, such
as partial troponin I degradation.7
The increase in myocardial water content occurred with-
out a significant reduction in COP. This is in keeping with
other reports modeling the capillary leak syndrome after
CPB.12,15 Hence there was movement of free water down os-
motic gradients across the endothelium into the myocardial
tissue. Water will move through AQPs, which exist abun-
dantly within the endothelium and sarcolemma, to leak into
the intracellular space of the myocardium if the osmotic
Figure 4. Myocardial aquaporin (AQP) 1 protein expression. AQP1
protein was obtained from the myocardium of non–cardiopulmo-
nary bypass (CPB) control animals (black column), lambs undergo-
ing CPB without aortic crossclamping (AXC; gray column), and
lambs undergoing CPB1AXC (white column). It was measured
by Western blotting, analyzed by means of densitometry, and nor-
malized to the expression of cardiac actin. Representative results
demonstrate no significant differences between groups (Mann–
Whitney U test). *P < .05. Data shown are presented as means
6 standard error of the mean.ovember 2008
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PFigure 5. Myocardial apoptosis. Repre-
sentative results of non–cardiopulmo-
nary bypass (CPB) control animals
(black column), lambs undergoing CPB
without aortic crossclamping (AXC;
gray column), and lambs undergoing
CPB1AXC (white column). A, Hematox-
ylin and eosin micrographs of ventricu-
lar myocardium taken at 3100
magnification. The CPB1AXC images
are suggestive of more tissue edema,
and there was no apparent necrosis.
Micrographs of TdT-mediated dUTP
nick-end labeling (TUNEL)–stained ven-
tricular myocardium are shown at3100
magnification. Appropriate positive and
negative controls were performed (data
not shown). No significant differences
were seen in TUNEL staining. B, Graph
of the results of active caspase 3 densi-
tometry for the 3 groups from Western
blot analysis, loading controlled with
cardiac actin. The animals undergoing
CPB1AXC demonstrated a significant
increase active caspase 3 protein,
which is suggestive of active early apo-
ptotic pathways (Mann–WhitneyU test).
*P < .05. Data shown are presented
as means6 standard error of the mean.gradient mandates this, as can occur early during reperfusion
as a result of intracellular lactate accumulation.16
AQP1 transcript was increased after CPB with ischemia
within the myocardium. This increase was specific to those
animals that had I/R and not CPB alone. This was a 2-fold
increase in transcript but without an associated protein
increase. AQP1 has been studied in a neonatal lamb heart pre-
viously in a deep hypothermic circulatory arrest model; no
change in AQP1 expression was found in this study.21 Poten-
tially, AQP1 expression might have been modified by induc-
ing deep hypothermia, as has been described in other
settings.29 Such modifications can affect edema formation
and function, as reported elsewhere30; however, the effect
of deep hypothermic circulatory arrest versus continuous
flow on AQP expression was not the focus of our study.
The finding that AQP1 transcript increased in the lambs
after CPB1AXC differs from our earlier results with a rat
isolated heart model. In the rat a brief period of global ische-
mia with reperfusion was not associated with changes in
AQP1 transcript or protein levels.17 Species differences, du-
ration of ischemia, and postischemic observation, as well as
use of CPB, might explain these differences. On the basisThe Journal of Thoraof our earlier work, we do not believe that species differences
adequately explain this difference because the AQP expres-
sion profile of the sheep is similar to those of the rat and hu-
man subject. Duration of ischemia can be important because
upregulation of AQP1 has been shown in interventions
lasting days rather than minutes to hours. In a fetal sheep
model anemia induced myocardial AQP1 increase over 5
days, suggesting that longer timeframes permitted adjust-
ments in myocardial AQP1 protein levels.20 Because exper-
iments of longer duration have permitted changes in AQP
transcript to be uncovered, it is likely that 9- to 12-hour ex-
periments would be required to determine protein changes.
We cannot determine the significance of the demonstrated
2-fold increase in AQP1 transcript, and this finding warrants
further study.
The suggestion by Calderone and associates22 that induc-
tion of apoptotic pathways can cause postischemic dysfunc-
tion, as well as later cell loss, is an intriguing hypothesis. We
sought to corroborate these findings but did not demonstrate
completed apoptosis as an important factor in LCOS over the
early time period. We did, however, demonstrate increased
expression of caspase 3 in the CPB1AXC group, which iscic and Cardiovascular Surgery c Volume 136, Number 5 1271
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function was not measured in our study. The negative predic-
tive value of TUNEL is greater than its positive predictive
value, especially because it can be positive during tissue re-
generation and recovery.23 We support the possibility that
apoptosis can be a contributing factor to LCOS, and this
might be particularly important in young infants having mul-
tiple operations with repetitive cell loss over time. Because
ischemia is the likely proapoptotic trigger, the findings rein-
force the importance of better management of the myocar-
dium during ischemia.
This study was limited by its small size and the fact that it
was conducted in animals. The animals also did not have
structural heart disease and hence no preoperative volume
or pressure loading. Measurements of vascular/ventricular
coupling, as well as load-independent measurements of sys-
tolic and diastolic function, will be required in future exper-
iments. The hemodynamic and functional monitoring used to
support our findings is somewhat rudimentary but equivalent
to techniques relied on in the clinical setting.
I/R was associated with a significant degree of myocardial
edema, clinically relevant dysfunction, and increased expres-
sion of AQP1. Edema formation is mostly related to ischemia
and not bypass: our findings do not support a causal role for
myocardial edema in the development of LCOS. Some ben-
efit can be gained by manipulation of water flux, possibly by
targeting AQP expression; however, the main focus in LCOS
research should be the prevention of postischemic dysfunc-
tion rather than the systemic inflammatory response to bypass
and generalized water accumulation. Analysis of AQP1
knockout mice with isolated cardiomyocytes and isolated
hearts will further our understanding of the role of AQPs in
myocardial water handling.
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CSPAppendix E1. Myocardial AQP1 mRNA and protein
analysis
Protein for Western blot analysis was prepared by using
whole-cell lysates from frozen tissue. Total RNA was
extracted from tissues by using Tri Reagent (Molecular
Research Center, Cincinnati, Ohio), followed by cDNA
synthesis with oligo dT and reverse transcriptase (Superscript
III; Invitrogen, Carlsbad, Calif). Quantitative reverse tran-
scriptase–polymerase chain reaction was performed with
LUX primers (Invitrogen) for sheep AQP1 (50-CGAGATCG
CCACTGTCATCCTCT[FAM]G-30; 50-CATTGAGGCCA
AGCGAGTTG-30), AQP4 (50-GACAGAAGAAAAGC1273.e1 The Journal of Thoracic and Cardiovascular SurgeryCATTACCTGT[FAM]G-30; 50-GATGCTGAGTCCAAAG
CAGAGG-30), and 18S (50-GACCTGCCGAGATTGAG
CAATAACAGG[FAM]C-30; 50-GTAGGGTAGGCACA
CGCTGAG-30) by using the Platinum PCR SuperMix-
UDG kit (Invitrogen). All samples were run in
duplicate. AQP levels were quantified during 45 cycles
by using a Rotor-Gene RG 3000A (Corbett Research,
Mortlake, New South Wales, Australia), and analysis
was performed with Rotor-Gene Real Time Analysis
Version 6.0 (Corbett Research). mRNA levels were quan-
tified by using 18S rRNA to normalize the raw AQP
signal.c November 2008
Egan et al Cardiopulmonary Support and PhysiologyTABLE E1. Baseline biochemical variables
Pre-CPB indices (mean 6 SEM)
n Hemoglobin (g/dL) Glucose (mmol/L) Lactate (mmol/L) Venous Saturation (%) COP (mOsm)
Control 4 10.5 6 0.8 6.5 6 1.0 1.5 6 0.3 78 6 14.9 13.8 6 1.3
CPB–AXC 3 10.3 6 0.2 5.8 6 2.3 1.4 6 0.5 72.5 6 16.9 12.3 6 1.5
CPB1AXC 6 10.2 6 0.4 5.7 6 0.4 2 6 0.7 76.8 6 4.7 14.6 6 0.5
CPB, Cardiopulmonary bypass; SEM, standard error of the mean; COP, colloid osmotic pressure; AXC, aortic crossclamp.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1273.e2
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